The American Journal of Medicine · 2009 · 172 citations · 29 references
MedicineInternal MedicineNephrologyRenal PathophysiologyRenal PharmacokineticsRenal PharmacotherapyAngiogenesisAntianginal TherapyRenal DiseaseRenal IschemiaRenal Vascular DiseaseVascular RegenerationRenal Adverse EffectsRenal Hemodynamic EffectsRenal Late EffectsVascular Endothelial Growth Factor InhibitionVascular Endothelial Growth Factor Inhibitors
29
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Alan Sandler, Robert J. Gray, Michael C. Perry et al. · New England Journal of Medicine · 2006 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +13
Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma
Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text
Medicine, Oncology, Pharmacology +14
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma
Bernard Escudier, Tim Eisen, Walter M. Stadler et al. · New England Journal of Medicine · 2007 · 4.8K citations · Full text
Medicine, Nephrology, Oncology +11
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Kathy D. Miller, Molin Wang, Julie R. Gralow et al. · New England Journal of Medicine · 2007 · 3.1K citations · Full text
Medicine, Oncology, Pharmacology +13